Clinical Safety and Tolerability of A2NTX, a Novel Low-Molecular-Weight Neurotoxin Derived from Botulinum Neurotoxin Subtype A2, in Comparison with Subtype A1 Toxins

por Takeuchi, Toshiaki, Okuno, Tsuyoshi, Miyashiro, Ai, Kohda, Tomoko, Miyamoto, Ryosuke, Izumi, Yuishin, Kozaki, Shunji, Kaji, Ryuji
Publicado 2021

A Pilot Study of A2NTX, a Novel Low-Molecular-Weight Neurotoxin Derived from Subtype A2 for Post-Stroke Lower Limb Spasticity: Comparison with OnabotulinumtoxinA

por Kaji, Ryuji, Miyashiro, Ai, Sato, Nori, Furumoto, Taiki, Takeuchi, Toshiaki, Miyamoto, Ryosuke, Kohda, Tomoko, Izumi, Yuishin, Kozaki, Shunji
Publicado 2022

MR Spectroscopy in Patients with Hereditary Diffuse Leukoencephalopathy with Spheroids and Asymptomatic Carriers of Colony-stimulating Factor 1 Receptor Mutation

por Abe, Takashi, Kawarai, Toshitaka, Fujita, Koji, Sako, Wataru, Terasawa, Yuka, Matsuda, Tsuyoshi, Sakai, Waka, Tsukamoto-Miyashiro, Ai, Matsui, Naoko, Izumi, Yuishin, Kaji, Ryuji, Harada, Masafumi
Publicado 2016